Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361815 · ClinicalTrials.gov registry record · NA
Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)
A NA study, sponsored by Brainsway.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT01361815 is a NA study that has completed, run by Brainsway. The registered enrollment target is 75 participants.
The verdict
NCT01361815, a NA study, has completed, sponsored by Brainsway.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of the study is to explore the Tolerability and Safety of the H-Coil deep Transcranial Magnetic Stimulation (TMS) in combination with Serotonin Selective Reuptake Inhibitor (SSRI) for Subjects with Major Depression Disorder (MDD) who Complete/ Discontinued the Deep TMS Multicenter study for Subjects with Major Depression Disorder (MDD) (Protocol# CTP-0001-00).
Interventions
- DEVICE H-Coil Deep TMS in combination with SSRIs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01361815
The ClinicalTrials.gov registry entry for NCT01361815 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brainsway, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which H-Coil Deep TMS in combination with SSRIs is the first listed.
NCT01361815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01361815 about?
NCT01361815 is a clinical study titled "Prospective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)". The purpose of the study is to explore the Tolerability and Safety of the H-Coil deep Transcranial Magnetic Stimulation (TMS) in combination with Serotonin Selective Reuptake Inhibitor (SSRI) for Subjects with Major Depression Disorder (MDD) who Complete/ Discontinued the Deep TMS Multicenter study ...
What is the current status of trial NCT01361815?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2011-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01361815?
The interventions under investigation include: H-Coil Deep TMS in combination with SSRIs (DEVICE).
Who is sponsoring clinical trial NCT01361815?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.